Literature DB >> 27930856

'ProtecTion' from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?

Luke L Wang1,2, Christopher J D Wallis3, Niranjan Sathianathen4, Nathan Lawrentschuk4,5, Declan G Murphy4,6, Robert Nam3, Daniel Moon1,2,4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27930856     DOI： 10.1111/bju.13734

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  2 in total

Review 1.  Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions.

Authors:  Benjamin A Greenberger; Victor E Chen; Robert B Den
Journal:  Front Oncol       Date:  2019-11-29       Impact factor: 6.244

2.  Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners.

Authors:  Penelope Schofield; Karla Gough; Amelia Hyatt; Alan White; Mark Frydenberg; Suzanne Chambers; Louisa G Gordon; Robert Gardiner; Declan G Murphy; Lawrence Cavedon; Natalie Richards; Barbara Murphy; Stephen Quinn; Ilona Juraskova
Journal:  Trials       Date:  2021-01-11       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.